AGALBRI Trademark

Trademark Overview


On Friday, September 18, 2015, a trademark application was filed for AGALBRI with the United States Patent and Trademark Office. The USPTO has given the AGALBRI trademark a serial number of 79174948. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, August 26, 2019. This trademark is owned by Novartis AG. The AGALBRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
agalbri

General Information


Serial Number79174948
Word MarkAGALBRI
Filing DateFriday, September 18, 2015
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, August 26, 2019
Registration Number4938941
Registration DateTuesday, April 19, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 2, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics
Translation of Words in MarkThe wording "AGALBRI" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, August 26, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSandoz AG
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH-4002 Basel
CH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH-4002 Basel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH-4002 Basel
CH

Trademark Events


Event DateEvent Description
Monday, January 22, 2024CHANGE OF OWNER RECEIVED FROM IB
Friday, May 29, 2020NOTIFICATION PROCESSED BY IB
Thursday, September 12, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Thursday, September 12, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, August 5, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 20, 2016FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 20, 2016FINAL DISPOSITION PROCESSED
Tuesday, July 19, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 19, 2016REGISTERED-PRINCIPAL REGISTER
Saturday, February 13, 2016NOTIFICATION PROCESSED BY IB
Tuesday, February 2, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 2, 2016PUBLISHED FOR OPPOSITION
Wednesday, January 27, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 27, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 13, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 29, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 21, 2015ASSIGNED TO LIE
Tuesday, December 15, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 9, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 9, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 9, 2015ASSIGNED TO LIE
Friday, November 27, 2015REFUSAL PROCESSED BY IB
Monday, November 23, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 16, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 16, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 6, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, November 6, 2015REFUSAL PROCESSED BY MPU
Friday, November 6, 2015APPLICATION FILING RECEIPT MAILED
Thursday, November 5, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 4, 2015NON-FINAL ACTION WRITTEN
Monday, November 2, 2015ASSIGNED TO EXAMINER
Monday, November 2, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 30, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, October 29, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB